Showing results (381-390 of 491) with videos related to
Sort By:
Pageof 50
Journal of the American College of Cardiology|September 6, 2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery diseaseDominick J Angiolillo, Joseph A Jakubowski, José Luis Ferreiro, et al.Blood|October 27, 2010
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancerJ Douglas Rizzo, Melissa Brouwers, Patricia Hurley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancerJ Douglas Rizzo, Melissa Brouwers, Patricia Hurley, et al.Journal of Medicinal Chemistry|June 20, 1997
Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIaM J Fisher, B Gunn, C S Harms, et al.Thrombosis and Haemostasis|April 11, 2014
Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trialJ G Diodati, J F Saucedo, T E Cardillo, et al.Journal of the American College of Cardiology|October 23, 2012
Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trialDavid Erlinge, Jurrien Ten Berg, David Foley, et al.The Oncologist|October 9, 2015
Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell TransplantationLee W Jones, Sean M Devlin, Molly A Maloy, et al.Blood Advances|April 12, 2021
Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AMLBrian C Shaffer, Jean-Benoit Le Luduec, Soo Park, et al.Journal of Pediatric Hematology/Oncology|December 11, 2014
Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging studyLori Styles, Darell Heiselman, Lori E Heath, et al.Blood|October 24, 2007
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline updateJ Douglas Rizzo, Mark R Somerfield, Karen L Hagerty, et al.Pageof 50